Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing

American Journal of Pathology

Volumn 170, Issue 4, 2007, Pages 1178-1191

  Maruyama, Kazuichi ^a,b   Asai, Jun ^a,c   Ii, Masaaki ^c   Thorne, Tina ^c   Losordo, Douglas W ^c,e   D'Amore, Patricia A ^b,d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CD31 ANTIGEN; GLUCOSE; INTERLEUKIN 1BETA; PODOPLANIN; PROTEIN LYVE 1; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3; DIFFERENTIATION ANTIGEN; GLYCOPROTEIN; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; VASCULOTROPIN A; XLKD1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA INJURY; DIABETES MELLITUS; DOWN REGULATION; DRUG MECHANISM; HETEROZYGOSITY; HOMOZYGOSITY; LYMPHANGIOGENESIS; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; WILD TYPE; WOUND HEALING IMPAIRMENT; ANIMAL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CHEMISTRY; CORNEA; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPH VESSEL; MACROPHAGE; METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; TRANSPLANTATION; WOUND HEALING;

ANIMALS; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION; BONE MARROW TRANSPLANTATION; CORNEA; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; GLUCOSE; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1BETA; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; WOUND HEALING;

EID: 34247874642     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060018     Document Type: Article

References (29)

1. Ross R, Odland G: Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol 1968, 39:152-168
2. Odland G, Ross R: Human wound repair. I. Epidermal regeneration. J Cell Biol 1968, 39:135-151
3. Polverini PJ, Cotran PS, Gimbrone Jr MA, Unanue ER: Activated macrophages induce vascular proliferation. Nature 1977, 269:804-806
4. Hong YK, Lange-Asschenfeldt B, Velasco P, Hirakawa S, Kunstfeld R, Brown LF, Bohlen P, Senger DR, Detmar M: VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J 2004, 18:1111-1113
5. Leibovich SJ, Ross R: The role of the macrophage in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol 1975, 78:71-100
6. DiPietro LA: Wound healing: the role of the macrophage and other immune cells. Shock 1995, 4:233-240
7. Oliver G, Detmar M: The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 2002, 16:773-783
8. Witte MH, Bernas MJ, Martin CP, Witte CL: Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc Res Tech 2001, 55:122-145
9. Ji RC: Characteristics of lymphatic endothelial cells in physiological and pathological conditions. Histol Histopathol 2005, 20:155-175
10. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA, Stein-Streilein J, Losordo DW, Streilein JW: Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005, 115:2363-2372
11. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G, Krober SM, Greinix H, Rosenmaier A, Karlhofer F, Wick N, Mazal PR: Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006, 12:230-234
12. Schledzewski K, Falkowski M, Moldenhauer G, Metharom P, Kzhyshkowska J, Ganss R, Demory A, Falkowska-Hansen B, Kurzen H, Ugurel S, Geginat G, Arnold B, Goerdt S: Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1(+), F4/80(+), CD11b(+) macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 2006, 209:67-77
13. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Dana MR, Wiegand SJ, Streilein JW: VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004, 113:1040-1050
14. Coleman DL: Diabetes-obesity syndromes in mice. Diabetes 1982, 31:1-6
15. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495
16. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S: Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000, 115:245-253
17. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R: PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990, 136:1235-1246
18. Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K, Jackson D: Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci 2002, 43:2127-2135
19. Chang L, Kaipainen A, Folkman J: Lymphangiogenesis: new mechanisms. Ann NY Acad Sci 2002, 979:111-119
20. Takeuchi M, Alard P, Streilein JW: TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol 1998, 160:1589-1597
21. Herembert T, Gogusev J, Zhu DL, Drueke TB, Marche P: Control ofvascular smooth-muscle cell growth by macrophage-colony-stimulating factor. Biochem J 1997, 325:123-128
22. Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP: Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 2002, 161:97-104
23. Bohlen HG, Niggl BA: Adult microvascular disturbances as a result of juvenile onset diabetes in Db/Db mice. Blood Vessels 1979, 16:269-276
24. Rutherford MS, Schook LB: Differential immunocompetence of macrophages derived using macrophage or granulocyte-macrophage colony-stimulating factor. J Leukoc Biol 1992, 51:69-76
25. Takashima A, Edelbaum D, Kitajima T, Shadduck RK, Gilmore GL, Xu S, Taylor RS, Bergstresser PR, Ariizumi K: Colony-stimulating factor-1 secreted by fibroblasts promotes the growth of dendritic cell lines (XS series) derived from murine epidermis. J Immunol 1995, 154:5128-5135
26. Singer AJ, Clark RA: Cutaneous wound healing. N Engl J Med 1999, 341:738-746
27. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R: Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000, 49:1451-1458
28. Falanga V: Wound healing and its impairment in the diabetic foot. Lancet 2005, 366:1736-1743
29. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K: Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004, 5:74-80